Non-Invasive Magnetic Peripheral Nerve Stimulation (mPNS) Treatment Offers New Hope for PDN Patients SAN DIEGO, Jan. 11, 2024 /PRNewswire/ -- Neuralace Medical, Inc., an innovator in pain management ...
In mid-2021, after a decade of R&D, Neuralace Medical earned FDA clearance for its Axon Therapy, a noninvasive treatment option for chronic pain caused by nerve damage. The road to its next regulatory ...
REBALANCE-HF early feasibility trial met objective of identifying responder group with demonstrated benefits in heart function, hemodynamics, and physical activity at 6 months SAVM procedure quick and ...
Axon regeneration and central nervous system repair represent critical frontiers in neuroscience research, offering promise for restoring communication and function after injury. Following trauma, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback